Desmopressin

Desmopressin

SCHEMBL204511

CC(=O)O.N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AVPR1AAVPR1BAVPR2

The experimentally established mechanism targets of Desmopressin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ AVPR1A known ✓ P37288 6/20 0.82
▸ AVPR2 known ✓ P30518 4/20 0.82
▸ AVPR1B known ✓ P47901 4/20 0.82
▸ OXTR P30559 9/20 0.82
▸ PTGS1 P23219 1/20 0.82
▸ TBXA2R P21731 1/20 0.69
▸ PDE4D Q08499 1/20 0.69
▸ PDE3A Q14432 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Desmopressin SCHEMBL29354819 1.00 OXTR (0.82) OXTRAVPR1AAVPR2AVPR1BPTGS1
Desmopressin SCHEMBL6021294 1.00 OXTR (0.82) OXTRAVPR1AAVPR2AVPR1BPTGS1
Desmopressin SCHEMBL347838 0.99 OXTR (0.81) OXTRAVPR1AAVPR2AVPR1BPTGS1
Desmopressin SCHEMBL28142694 0.99 OXTR (0.81) OXTRAVPR1AAVPR2AVPR1BPTGS1
Desmopressin SCHEMBL4642385 0.99 OXTR (0.81) OXTRAVPR1AAVPR2AVPR1BPTGS1
SCHEMBL23382246 0.98 OXTR (0.85) OXTRAVPR1AAVPR2AVPR1BPTGS1
Desmopressin SCHEMBL15933169 0.98 OXTR (0.85) OXTRAVPR1AAVPR2AVPR1BPTGS1
Desmopressin SCHEMBL2687079 0.98 OXTR (0.85) OXTRAVPR1AAVPR2AVPR1BPTGS1
Desmopressin SCHEMBL21131126 0.98 OXTR (0.85) OXTRAVPR1AAVPR2AVPR1BPTGS1
Desmopressin SCHEMBL10053268 0.98 OXTR (0.85) OXTRAVPR1AAVPR2AVPR1BPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3692 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260076872-A1 POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME SIO2 MEDICAL PRODUCTS LLC (US) 2026-03-19 — — US claimed
US-12576125-B2 Desmopressin oral compositions TULEX PHARMACEUTICALS INC. (US) 2026-03-17 — — US claimed
EP-4687859-A2 DESMOPRESSIN ORAL COMPOSITIONS TULEX PHARMACEUTICALS, INC. (US) 2026-02-11 — — EP claimed
US-12534571-B2 Amphiphilic block copolymer, preparation method thereof and nanomicelle drug-loading system SHANGHAI BEST-LINK BIOSCIENCE, LLC (CN) 2026-01-27 — — US claimed
US-20250281567-A1 DESMOPRESSIN ORAL COMPOSITIONS TULEX PHARMACEUTICALS INC. 2025-09-11 — — US claimed
EP-4603095-A2 IMPROVED PHARMACEUTICAL FORMULATIONS Ferring B.V. (NL) 2025-08-20 — — EP claimed
US-20250242092-A1 SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS SIO2 MEDICAL PRODUCTS INC (US) 2025-07-31 — — US claimed
EP-4577186-A1 HAEMORRHAGE INHIBITING COMPOSITIONS AND METHODS INVOLVING THE SAME Stellaris Pharmaceuticals ApS (DK) 2025-07-02 — — EP claimed
US-12343372-B2 Desmopressin oral compositions TULEX PHARMACEUTICALS INC. (US) 2025-07-01 — — US claimed
EP-3787596-B1 IMPROVED PHARMACEUTICAL FORMULATIONS FERRING BV (NL) 2025-06-25 — — EP claimed
EP-0668926-A1 MULTIPLE COAGULATION TEST DEVICE AND METHOD GOLDSTEIN, Sheldon (US) 1995-08-30 — — EP claimed
WO-1995001185-A1 STABILIZED PHARMACEUTICAL PEPTIDE COMPOSITIONS FERRING B.V. (NL) 1995-01-12 — — WO claimed
US-5366869-A Multiple coagulation test device and method COAGULATION SCIENCES LLC 1994-11-22 — — US claimed
WO-1994011527-A1 MULTIPLE COAGULATION TEST DEVICE AND METHOD GOLDSTEIN SHELDON (US) 1994-05-26 — — WO claimed
US-5288498-A Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 1994-02-22 — — US claimed
US-5288497-A Compositions of oral dissolvable medicaments THE UNIVERSITY OF UTAH (US) 1994-02-22 — — US claimed
EP-0487520-A4 COMPRESSED POWDER MEDICAMENTS — 1992-08-12 — — EP claimed
US-5132114-A Compositions and methods of manufacture of compressed powder medicaments UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 1992-07-21 — — US claimed
EP-0487520-A1 COMPRESSED POWDER MEDICAMENTS. ANESTA CORP (US) 1992-06-03 — — EP claimed
WO-1991003099-A1 COMPRESSED POWDER MEDICAMENTS ANESTA CORPORATION (US) 1991-03-07 — — WO claimed
Send feedback